Journal: Structure / Year: 2023 Title: Structural characterization of human tryptophan hydroxylase 2 reveals that L-Phe is superior to L-Trp as the regulatory domain ligand. Authors: Ida M Vedel / Andreas Prestel / Zhenwei Zhang / Natalia T Skawinska / Holger Stark / Pernille Harris / Birthe B Kragelund / Günther H J Peters / Abstract: Tryptophan hydroxylase 2 (TPH2) catalyzes the rate-limiting step in serotonin biosynthesis in the brain. Consequently, regulation of TPH2 is relevant for serotonin-related diseases, yet the ...Tryptophan hydroxylase 2 (TPH2) catalyzes the rate-limiting step in serotonin biosynthesis in the brain. Consequently, regulation of TPH2 is relevant for serotonin-related diseases, yet the regulatory mechanism of TPH2 is poorly understood and structural and dynamical insights are missing. We use NMR spectroscopy to determine the structure of a 47 N-terminally truncated variant of the regulatory domain (RD) dimer of human TPH2 in complex with L-Phe, and show that L-Phe is the superior RD ligand compared with the natural substrate, L-Trp. Using cryo-EM, we obtain a low-resolution structure of a similarly truncated variant of the complete tetrameric enzyme with dimerized RDs. The cryo-EM two-dimensional (2D) class averages additionally indicate that the RDs are dynamic in the tetramer and likely exist in a monomer-dimer equilibrium. Our results provide structural information on the RD as an isolated domain and in the TPH2 tetramer, which will facilitate future elucidation of TPH2's regulatory mechanism.
Type: L-peptide linking / Mass: 165.189 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: C9H11NO2 / Feature type: SUBJECT OF INVESTIGATION
Has ligand of interest
Y
-
Experimental details
-
Experiment
Experiment
Method: SOLUTION NMR
NMR experiment
Conditions-ID
Experiment-ID
Solution-ID
Sample state
Spectrometer-ID
Type
1
7
1
isotropic
2
2D 1H-15N HSQC
1
1
1
isotropic
2
3D HN(CA)CB
1
2
1
isotropic
2
3DHN(COCA)CB
1
3
1
isotropic
2
3D HNCO
1
4
1
isotropic
2
3DHN(CA)CO
1
5
1
isotropic
2
2D 1H-13C HSQC aliphatic
1
12
1
isotropic
2
2D 1H-13C HSQC aromatic
1
6
1
isotropic
1
3D 1H-13C NOESY aliphatic
1
8
1
isotropic
1
3D 1H-15N NOESY
1
9
1
isotropic
1
3D HNCA
1
10
1
isotropic
1
3D 1H-13C NOESY aliphatic 13C/15N filtered
1
11
1
isotropic
1
3D 1H-15N NOESY 13C/15N filtered
1
19
1
isotropic
1
3D (H)CCH-TOCSY
1
18
1
isotropic
2
2D 1H-13C HSQC aliphatic amino acid specific
1
16
2
isotropic
1
2D 1H-13C HSQC aromatic
1
17
2
isotropic
1
2D 1H-13C HSQC aliphatic
-
Sample preparation
Details
Type
Solution-ID
Contents
Label
Solvent system
solution
1
1.1 mM [U-99% 13C; U-99% 15N] Tryptophan hydroxylase 2 (GP+ 48 to 145), 10 mM L-Phe, 20 mM sodium phosphate, 100 mM ammonium sulfate, 125 uM DSS, 95% H2O/5% D2O
Protein
95% H2O/5% D2O
solution
2
0.45 mM Tryptophan hydroxylase 2 (GP+ 48 to 145), 2.6 mM [U-13C; U-15N] L-Phe, 20 mM sodium phosphate, 100 mM ammonium sulfate, 125 uM DSS, 95% H2O/5% D2O
L-Phe
95% H2O/5% D2O
Sample
Conc. (mg/ml)
Component
Isotopic labeling
Solution-ID
1.1mM
Tryptophanhydroxylase2 (GP+ 48to145)
[U-99% 13C; U-99% 15N]
1
10mM
L-Phe
none
1
20mM
sodiumphosphate
none
1
100mM
ammoniumsulfate
none
1
125uM
DSS
none
1
0.45mM
Tryptophanhydroxylase2 (GP+ 48to145)
none
2
2.6mM
L-Phe
[U-13C; U-15N]
2
20mM
sodiumphosphate
none
2
100mM
ammoniumsulfate
none
2
125uM
DSS
none
2
Sample conditions
Ionic strength: 0.344 M / Label: Standard / pH: 7.0 / Pressure: 1 atm / Temperature: 303 K
-
NMR measurement
NMR spectrometer
Type
Manufacturer
Model
Field strength (MHz)
Spectrometer-ID
Bruker AVANCE III
Bruker
AVANCEIII
750
1
Bruker AVANCE III
Bruker
AVANCEIII
600
2
-
Processing
NMR software
Name
Version
Developer
Classification
X-PLOR NIH
2.44
Schwieters, Kuszewski, TjandraandClore
refinement
CYANA
3.98.5
Guntert, MumenthalerandWuthrich
structurecalculation
CcpNmr Analysis
2.4.2
CCPN
chemicalshiftassignment
CcpNmr Analysis
2.4.2
CCPN
peakpicking
NMRPipe
Delaglio, Grzesiek, Vuister, Zhu, PfeiferandBax
processing
TopSpin
3.5
BrukerBiospin
processing
qMDD
Kazimierczuk, Orekhov
processing
TALOS
Cornilescu, DelaglioandBax
dataanalysis
Refinement
Method: simulated annealing / Software ordinal: 1
NMR representative
Selection criteria: lowest energy
NMR ensemble
Conformer selection criteria: structures with the lowest energy Conformers calculated total number: 100 / Conformers submitted total number: 20
+
About Yorodumi
-
News
-
Feb 9, 2022. New format data for meta-information of EMDB entries
New format data for meta-information of EMDB entries
Version 3 of the EMDB header file is now the official format.
The previous official version 1.9 will be removed from the archive.
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi